Beta blockers are dangerous and should not be used in patients with chronic heart failure.

The original concern made sense. A failing heart was already struggling to pump, and beta blockers slow the heart rate and reduce the force of each contraction. Giving one to a patient with heart failure could therefore look like deliberately weakening an already weak pump.

But chronic heart failure is not only a problem of weak contractions. The body responds by keeping the sympathetic nervous system—the system that releases adrenaline-like signals—persistently activated. That may help briefly, but over months and years it can promote abnormal rhythms, harmful changes in the heart muscle, and further decline.

Beginning in the 1970s, Swedish clinicians including Finn Waagstein cautiously tested beta blockers in selected patients with stable chronic heart failure. Larger randomized trials later showed that certain beta blockers could reduce hospitalizations and deaths when introduced carefully and increased gradually.

The old concern still matters in the wrong setting. Starting or rapidly increasing a beta blocker during unstable, acutely worsening heart failure can be dangerous. The correction applies to carefully managed long-term treatment in appropriate stable patients.